| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39ae96c0ecc22ff90ff986371a3cea0f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate |
1991-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a6233695bd2c25b92d429dcb6fe4a7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57d7c1e55d27cd8bf4e4a7a32e3d179d |
| publicationDate |
1992-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0488041-A2 |
| titleOfInvention |
A pharmaceutical composition for cytomegalovirus infection |
| abstract |
Use of a compound of the formulan n or a pharmaceutically acceptable salt thereof for the preparation of a medicament for preventing or treating infectious diseases due to Cytomegalovirus. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9323066-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5492896-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5646121-A |
| priorityDate |
1990-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |